Dimensional Fund Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Dimensional Fund Advisors’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,057	Closed	-$16K	–	3528
2022 Q3	$16K	Sell	13,057 -37,775	-74%	-$40.7K	﹤0.01%	3472
2022 Q2	$32K	Sell	50,832 -4,997	-9%	-$3.84K	﹤0.01%	3428
2022 Q1	$64K	Buy	55,829 +2,860	+5%	+$3.42K	﹤0.01%	3441
2021 Q4	$119K	Sell	52,969 -13,100	-20%	-$32.9K	﹤0.01%	3414
2021 Q3	$226K	Sell	66,069 -36,642	-36%	-$113K	﹤0.01%	3330
2021 Q2	$307K	Buy	+102,711	New	+$325K	﹤0.01%	3251
2020 Q4	–	Sell	-295,795	Closed	-$346K	–	3367
2020 Q3	$346K	Sell	295,795 -597,526	-67%	-$614K	﹤0.01%	3128
2020 Q2	$808K	Sell	893,321 -97,264	-10%	-$92.7K	﹤0.01%	2991
2020 Q1	$830K	Hold	990,585	–	–	﹤0.01%	2954
2019 Q4	$951K	Sell	990,585 -80,869	-8%	-$88.7K	﹤0.01%	3017
2019 Q3	$1.1M	Hold	1,071,454	–	–	﹤0.01%	2988
2019 Q2	$1.93M	Sell	1,071,454 -19,865	-2%	-$32K	﹤0.01%	2914
2019 Q1	$2.05M	Sell	1,091,319 -9,766	-0.9%	-$14.3K	﹤0.01%	2895
2018 Q4	$1.3M	Buy	1,101,085 +35,211	+3%	+$63.3K	﹤0.01%	2961
2018 Q3	$2.89M	Buy	1,065,874 +133,504	+14%	+$276K	﹤0.01%	2833
2018 Q2	$1.78M	Buy	932,370 +198,098	+27%	+$400K	﹤0.01%	2913
2018 Q1	$1.54M	Buy	734,272 +317,583	+76%	+$681K	﹤0.01%	2913
2017 Q4	$846K	Buy	416,689 +325,736	+358%	+$676K	﹤0.01%	3020
2017 Q3	$121K	Sell	90,953 -561,528	-86%	-$697K	﹤0.01%	3259
2017 Q2	$1.02M	Buy	652,481 +160,814	+33%	+$310K	﹤0.01%	2975
2017 Q1	$1.59M	Buy	+491,667	New	+$1.21M	﹤0.01%	2881
2015 Q4	–	Sell	-247,069	Closed	-$2.09M	–	3351
2015 Q3	$2.09M	Sell	247,069 -138,868	-36%	-$1.28M	﹤0.01%	2810
2015 Q2	$4.22M	Sell	385,937 -4,713	-1%	-$60.5K	﹤0.01%	2622
2015 Q1	$5.46M	Hold	390,650	–	–	﹤0.01%	2524
2014 Q4	$6.6M	Hold	390,650	–	–	﹤0.01%	2451
2014 Q3	$5.24M	Sell	390,650 -15,058	-4%	-$179K	﹤0.01%	2531
2014 Q2	$5.17M	Buy	405,708 +31,573	+8%	+$329K	﹤0.01%	2555
2014 Q1	$4.45M	Sell	374,135 -3,638	-1%	-$48.8K	﹤0.01%	2599
2013 Q4	$5.22M	Sell	377,773 -9,566	-2%	-$135K	﹤0.01%	2537
2013 Q3	$6.76M	Sell	387,339 -118,292	-23%	-$2.27M	0.01%	2390
2013 Q2	$8.22M	Buy	+505,631	New	+$15.6M	0.01%	2175

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Dimensional Fund Advisors's INFI Position: Q4 2022 in Review

Dimensional Fund Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2022, closing a stake of 13,057 shares — an estimated $16K sold.

Dimensional Fund Advisors first reported a position in INFI in Q2 2013 and held it in 31 quarters. The position peaked at $8.22M in Q2 2013. 68 funds tracked by Wall St. Rank hold INFI as of Q4 2022.

Dimensional Fund Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Dimensional Fund Advisors sold 13,057 Infinity Pharmaceuticals, Inc. shares in Q4 2022, an estimated $16K.
Dimensional Fund Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 31 quarters.
Dimensional Fund Advisors's Infinity Pharmaceuticals, Inc. position peaked at $8.22M in Q2 2013.
68 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2022.

Based on Dimensional Fund Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.